Previsioni di mercato degli agenti di embolizzazione in Europa fino al 2028 - Impatto del COVID-19 e analisi regionale per prodotto (bobine, tappi, perline/particelle, palloncini staccabili, colla, spugne, embolici liquidi, sclerosanti, agenti precipitanti e altri), applicazione (oncologia, neurologia , urologia, cardiologia, malattie vascolari periferiche e altri) e utente finale (ospedali, centri cardiaci, centri chirurgici ambulatoriali e altri)

Introduzione al mercato

Il mercato europeo degli agenti di embolizzazione comprende i mercati consolidati di Germania, Francia, Regno Unito, Spagna, Italia e resto d\'Europa. L’Europa occupa una posizione significativa nel mercato globale degli agenti di embolizzazione e si stima registrerà un robusto tasso di crescita nel periodo di previsione. Si prevede che la crescita del mercato nella regione sarà dovuta all’invecchiamento della popolazione, alla crescente prevalenza di tumori e aneurismi cerebrali e al crescente numero di lanci di prodotti che saranno probabilmente i principali fattori che guideranno la crescita di questo mercato in Europa. Gli aneurismi cerebrali possono ulteriormente portare a sanguinamento nel cervello noto come ictus emorragico. La prevalenza dell\'ictus in Germania è stata registrata negli ultimi anni. Secondo i dati pubblicati nel rapporto The Burden of Stroke in Europe condotto dal King\'s College di Londra per la Stroke Alliance for Europe, l\'incidenza dell\'ictus è di circa 88.922 casi di ictus, ovvero 51,7 ictus ogni 100.000 abitanti all\'anno in Germania. La prevalenza di ictus in Germania è stata di circa 526.774, pari a 338,5 ictus ogni 100.000 abitanti. Il Paese ha anche un tasso significativo di mortalità per ictus, ovvero 75.861 decessi dovuti a ictus all\'anno. Le stime rivelano che si prevede che l’incidenza degli ictus in Germania aumenterà del 30% entro la fine del 2035. Inoltre, si prevede che i tassi di prevalenza e mortalità saliranno rispettivamente al 19% e al 40% entro il 2035. Alcuni dei fattori di rischio prevalenti che portano all’ictus sono l’ipertensione, il fumo, il colesterolo alto e l’aumento del livello di glucosio. Anche gli operatori del mercato del paese si stanno concentrando sul lancio di prodotti innovativi. Si prevede inoltre che tali sviluppi accelereranno la crescita del mercato. Ad esempio, nell’aprile 2020, Phenox GmbH, pioniere delle tecnologie innovative per le malattie neurovascolari, ha lanciato il nuovo dispositivo di modulazione del flusso p64 MW. Il dispositivo di modulazione del flusso p64 MW, un dispositivo simile a uno stent di nuova generazione, è destinato a deviare il flusso sanguigno lontano dall\'aneurisma

In Europa, Italia, Spagna e Francia hanno hanno riportato il maggior numero di casi di Covid-19. Secondo il Centro europeo per la prevenzione e il controllo delle malattie (ECDC), a giugno 2021, l’Europa ha registrato finora 736.553 decessi dovuti a COVID-19. I paesi di tutta Europa stanno assistendo a una recrudescenza dei casi di COVID-19 dopo aver mitigato con successo le epidemie all’inizio dell’anno. Molti paesi dichiarano ogni giorno più casi rispetto al conteggio giornaliero dei casi riportato durante la prima ondata di pandemia. Secondo l’ECDC, i blocchi verranno reintrodotti nel Regno Unito, Spagna, Italia e Irlanda. Inoltre, molti governi nazionali stanno lavorando per potenziare le proprie capacità di terapia cellulare, terapia genica e medicina rigenerativa. Inoltre, nel Regno Unito, la pratica del cancro e delle malattie neurologiche è cambiata. L’aumento del COVID-19 ha influenzato la diagnosi e il trattamento delle malattie, a causa della diversificazione del personale medico e della decisione di concentrarsi sul trattamento dei malati critici. Molte organizzazioni di ricerca si stanno concentrando maggiormente sugli studi sul COVID e stanno lavorando duramente per comprendere meglio il virus. L’Accademia Europea di Neurologia (EAN) ha lanciato un’indagine sui sintomi neurologici nei pazienti affetti da COVID-19 per comprendere meglio le manifestazioni neurologiche della malattia. Pertanto, la crescente attenzione alla SARS-CoV-2 ha limitato la crescita del mercato europeo degli agenti di embolizzazione negli ultimi due anni.

Panoramica e dinamiche del mercato

Si prevede che il mercato degli agenti di embolizzazione in Europa crescerà da 795,79 milioni di dollari nel 2021 a 1.282,95 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 7,1% dal 2021 al 2028. Nel settembre 2021 il dispositivo di embolizzazione Medtronic è stato colpito da un\'altra bobina di richiamo di Classe I staccata. La FDA ha classificato un altro richiamo del dispositivo di embolizzazione Pipeline Flex di Medtronic per il trattamento degli aneurismi cerebrali come evento di Classe I dopo aver ricevuto segnalazioni di 59 malfunzionamenti, 10 lesioni gravi e due decessi. Nel luglio 2021 Terumo presenta il nuovo tappo vascolare AZUR e il sistema di embolizzazione del microcatetere periferico PG Pro, il primo e unico tappo compatibile con un microcatetere e in grado di occludere arterie fino a 8 mm di diametro. L\'ultima aggiunta all\'ampio portafoglio di embolizzazione di Terumo è consigliata per l\'uso nelle arterie del sistema vascolare periferico per limitare o arrestare il flusso sanguigno. Inoltre, nel maggio 2021, Shanghai MicroPort NeuroTech Co., Ltd. ha ricevuto l\'approvazione CE dall\'Unione Europea per il suo sistema di embolizzazione delle bobine Numen (Numen) e il sistema di distacco delle bobine Numen FR (Numen FR). Questi vengono utilizzati per le procedure di embolizzazione con spirale per il trattamento dell\'aneurisma intracranico. L\'azienda si concentra su attività di ricerca e sviluppo per sviluppare soluzioni innovative su interventi cerebrovascolari e neuro. Inoltre, nel dicembre 2020, Terumo Corporation ha lanciato in Giappone il WEB Embolization System (nome del prodotto in Giappone: Woven EndoBridge Device), un dispositivo per il trattamento dell\'aneurisma intrasaccaculare. Il dispositivo WEB è un innovativo dispositivo di interruzione del flusso intrasacculare e fornisce nuove opzioni di trattamento per i casi di aneurisma cerebrale. Tali progressi basati sulle moderne tecnologie introdurranno probabilmente nuove tendenze future nel mercato europeo degli agenti di embolizzazione nei prossimi anni.

Segmenti chiave del mercato

In base al prodotto, il mercato è segmentato in bobine, perline/particelle, tappi, palloncini staccabili, colla, spugne, embolici liquidi, sclerosanti, agenti precipitanti, altri. Il segmento perle/particelle ha detenuto la quota maggiore del mercato nel 2020. In base alle bobine, il mercato è suddiviso in bobine rimovibili e bobine spingebili. Il segmento delle bobine spingebili ha detenuto la quota maggiore del mercato nel 2020. In base alle perle/particelle il mercato è suddiviso in sferiche e non sferiche. Il segmento non sferico spingebile deteneva la quota maggiore del mercato nel 2020. In base all\'applicazione, il mercato è segmentato in neurologia, oncologia, cardiologia, malattie vascolari periferiche e altri. Nel 2020, il segmento oncologico deterrà probabilmente la quota maggiore del mercato. Il mercato degli agenti di embolizzazione per utente finale è segmentato in ospedali, centri chirurgici ambulatoriali, centri cardiaci e altri. Il segmento ospedaliero ha detenuto la quota maggiore del mercato nel 2020.

Principali fonti e aziende elencate

Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato degli agenti di embolizzazione in Europa sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. . Le principali società elencate nel rapporto sono Abbott; Società scientifica di Boston; Cook Medical LLC; DePuy sintetizza; CORPORAZIONE KANEKA; Medtronic; Merito Medical Systems Inc; Penombra, Inc.; Stryker Corporation; e Terumo Corporation, tra gli altri.

Motivi per acquistare il rapporto

Comprendere il panorama del mercato europeo degli agenti di embolizzazione e identificare i segmenti di mercato che hanno maggiori probabilità di garantire un forte rendimento
Stai al passo con i tempi comprendendo il panorama competitivo in continua evoluzione del mercato europeo degli agenti di embolizzazione
Pianifica in modo efficiente fusioni, acquisizioni e partnership si occupa del mercato europeo degli agenti di embolizzazione identificando i segmenti di mercato con le vendite probabili più promettenti
Aiuta a prendere decisioni aziendali consapevoli attraverso un\'analisi perspicace e completa delle prestazioni di mercato dei vari segmenti dell\'embolizzazione europea mercato degli agenti
Ottieni previsioni sulle entrate del mercato per vari segmenti dal 2021 al 2028 nella regione europea.

SEGMENTAZIONE DEL MERCATO DEGLI AGENTI EMBOLIZZATORI IN EUROPA

Per prodotto

Bobine
Bobine rimovibili
Bobine spingebili
Perline/Particelle
Sferico
< span>Non sferico
Spine
Palloncini staccabili
Colla
Spugna
Embolici liquidi
Sclerosanti
Agenti precipitanti
Altri

Per Applicazione

Per Utente finale

Ospedali
Centri cardiaci
Ambulatoriale Centri chirurgici
Altri

Per Paese

Profili aziendali

1.           Introduction
1.1       Scope of the Study
1.2       The Insight Partners Research Report Guidance
1.3       Market Segmentation
1.3.1        Europe Embolization Agents Market – By Product
1.3.2        Europe Embolization Agents Market – By Application
1.3.3        Europe Embolization Agents Market – By End User
1.3.4        Europe Embolization Agents Market – By Country
2.           Europe Embolization Agents Market – Key Takeaways
3.       Research Methodology
3.1       Coverage
3.2       Secondary Research
3.3       Primary Research
4.           Europe Embolization Agents Market – Market Landscape
4.1       Overview
4.2       PEST Analysis
4.2.1        Europe– PEST Analysis
4.3       Experts Opinion
5.           Europe Embolization Agents Market– Key Market Dynamics
5.1       Market Drivers
5.1.1        Growing in the Incidence of Tumors and Aneurysms
5.1.1        Rise Incidence of Hypertension, Obesity, Smoking, and Alcoholism
5.2       Market Restraints
5.2.1        Huge Cost of Embolization Agents
5.3       Market Opportunities
5.3.1        Rising Geriatric Population Base
5.4       Future Trends
5.4.1        Technological Advancements in Embolization Products and Procedures
5.5       Impact analysis
6.           Embolization Agents Market – Europe Analysis
6.1       Europe Embolization Agents Market Revenue Forecast and Analysis
7.           Europe Embolization Agents Market Analysis – By Product
7.1       Overview
7.2       Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)
7.3       Coils
7.3.1        Overview
7.3.2        Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.3.2.1      Detachable Coils
7.3.2.1.1       Detachable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.1.2       Detachable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2      Pushable Coils
7.3.2.2.1       Pushable Coil Market Revenue and Forecast to 2028 (US$ Mn)
7.3.2.2.2       Pushable Coil Market Revenue and Forecasts to 2028 (US$ Mn)
7.4       Beads/Particles
7.4.1        Overview
7.4.2        Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.4.2.1      Spherical
7.4.2.1.1       Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.1.2       Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.2.2      Non-Spherical
7.4.2.2.1       Non-Spherical Market Revenue and Forecast to 2028 (US$ Mn)
7.4.2.2.2       Non-Spherical Market Revenue and Forecasts to 2028 (US$ Mn)
7.5       Plugs
7.5.1        Overview
7.5.2        Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.6       Detachable Balloons
7.6.1        Overview
7.6.2        Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.7       Glue
7.7.1        Overview
7.7.2        Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.8       Sponge
7.8.1        Overview
7.8.2        Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.9       Liquid Embolics
7.9.1        Overview
7.9.2        Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.10    Sclerosants
7.10.1     Overview
7.10.2     Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.11    Precipitating Agents
7.11.1     Overview
7.11.2     Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
7.12    Others
7.12.1     Overview
7.12.2     Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
8.           Europe Embolization Agents Market Analysis – By Application
8.1       Overview
8.2       Europe Embolization Agents Market, by Application 2021 & 2028 (%)
8.3       Oncology
8.3.1        Overview
8.3.2        Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.4       Neurology
8.4.1        Overview
8.4.2        Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.5       Urology
8.5.1        Overview
8.5.2        Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.6       Cardiology
8.6.1        Overview
8.6.2        Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.7       Peripheral Vascular Diseases
8.7.1        Overview
8.7.2        Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
8.8       Others
8.8.1        Overview
8.8.2        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.           Europe Embolization Agents Market Analysis – By End User
9.1       Overview
9.2       Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)
9.3       Hospitals
9.3.1        Overview
9.3.2        Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.4       Cardiac Centers
9.4.1        Overview
9.4.2        Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.5       Ambulatory Surgical Centers
9.5.1        Overview
9.5.2        Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
9.6       Others
9.6.1        Overview
9.6.2        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
10.        Europe Embolization Agents Market – Country Analysis
10.1    Europe: Embolization Agents Market
10.1.1     Overview
10.1.2     Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)
10.1.2.1    Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1    Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2    Germany: Embolization Agents Market, by Product– Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.2.1        Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2.2        Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3    Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.4    Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2    France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1    France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2    France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.2.1        France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2.2        France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3    France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.4    France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3    UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1    UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2    UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.2.1        UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.2        UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3    UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.4    UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4    Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.1    Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2    Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.2.1        Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3    Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4    Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.4.5    Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5    Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.1    Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.2    Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.2.1        Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.2.2        Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.5.3    Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.5.4    Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6    Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.1    Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.2    Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.2.1        Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.2.2        Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
10.1.2.6.3    Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.2.6.4    Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11.        Impact Of COVID-19 Pandemic on Europe Embolization Agents Market
11.1    Europe: Impact Assessment Of COVID-19 Pandemic
12.        Europe Embolization Agents Market–Industry Landscape
12.1    Overview
12.2    Organic Developments
12.2.1     Overview
12.3    Inorganic Developments
12.3.1     Overview
13.        Company Profiles
13.1    Medtronic
13.1.1     Key Facts
13.1.2     Business Description
13.1.3     Products and Services
13.1.4     Financial Overview
13.1.5     SWOT Analysis
13.1.6     Key Developments
13.2    Terumo Corporation
13.2.1     Key Facts
13.2.2     Business Description
13.2.3     Products and Services
13.2.4     Financial Overview
13.2.5     SWOT Analysis
13.2.6     Key Developments
13.3    Cook Medical LLC
13.3.1     Key Facts
13.3.2     Business Description
13.3.3     Products and Services
13.3.4     Financial Overview
13.3.5     SWOT Analysis
13.3.6     Key Developments
13.4    Boston Scientific Corporation
13.4.1     Key Facts
13.4.2     Business Description
13.4.3     Products and Services
13.4.4     Financial Overview
13.4.5     SWOT Analysis
13.4.6     Key Developments
13.5    Abbott
13.5.1     Key Facts
13.5.2     Business Description
13.5.3     Products and Services
13.5.4     Financial Overview
13.5.5     SWOT Analysis
13.5.6     Key Developments
13.6    Stryker Corporation
13.6.1     Key Facts
13.6.2     Business Description
13.6.3     Products and Services
13.6.4     Financial Overview
13.6.5     SWOT Analysis
13.6.6     Key Developments
13.7    Penumbra, Inc.
13.7.1     Key Facts
13.7.2     Business Description
13.7.3     Products and Services
13.7.4     Financial Overview
13.7.5     SWOT Analysis
13.7.6     Key Developments
13.8    Merit Medical Systems Inc.
13.8.1     Key Facts
13.8.2     Business Description
13.8.3     Products and Services
13.8.4     Financial Overview
13.8.5     SWOT Analysis
13.8.6     Key Developments
13.9    DePuy Synthes
13.9.1     Key Facts
13.9.2     Business Description
13.9.3     Products and Services
13.9.4     Financial Overview
13.9.5     SWOT Analysis
13.9.6     Key Developments
13.10 KANEKA CORPORATION
13.10.1   Key Facts
13.10.2   Business Description
13.10.3   Products and Services
13.10.4   Financial Overview
13.10.5   SWOT Analysis
13.10.6   Key Developments
14.        Appendix
14.1    About The Insight Partners
14.2    Glossary of Terms

LIST OF TABLES
Table 1.             Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ million)
Table 2.             Germany: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 3.             Germany: Embolization Agents Market, by Coils– Revenue and Forecast to 2028 (USD Million)
Table 4.             Germany Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 5.             Germany: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 6.             Germany: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 7.             France: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 8.             France: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 9.             France: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 10.          France: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 11.          France: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 12.          UK: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 13.          UK: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 14.          UK: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 15.          UK: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 16.          UK: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17.          Spain: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 18.          Spain: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 19.          Spain: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 20.          Spain: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 21.          Spain: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 22.          Italy: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 23.          Italy: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 24.          Italy: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 25.          Italy: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 26.          Italy: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 27.          Rest of Europe: Embolization Agents Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 28.          Rest of Europe: Embolization Agents Market, by Coils – Revenue and Forecast to 2028 (USD Million)
Table 29.          Rest of Europe: Embolization Agents Market, by Beads/ Particles – Revenue and Forecast to 2028 (USD Million)
Table 30.          Rest of Europe: Embolization Agents Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 31.          Rest of Europe: Embolization Agents Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 32.          Organic Developments Done by Companies
Table 33.          Inorganic Developments Done by Companies
Table 34.          Glossary of Terms, Europe Embolization Agents Market

LIST OF FIGURES
Figure 1.           Europe Embolization Agents Market Segmentation
Figure 2.           Europe Embolization Agents Market Segmentation, By Country
Figure 3.           Europe Embolization Agents Market Overview
Figure 4.           Beads/ Particles Segment Held the Largest Share of the Product Segment in Europe Embolization Agents Market
Figure 5.           UK to Show Significant Growth During Forecast Period
Figure 6.           Europe and PEST Analysis
Figure 7.           Europe Embolization Agents Market Impact Analysis of Drivers and Restraints
Figure 8.           Europe Embolization Agents Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9.           Europe Embolization Agents Market Revenue Share, by Product (2021 and 2028)
Figure 10.        Coils: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 11.        Beads/Particles: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12.        Plugs: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13.        Detachable Balloons: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14.        Glue: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15.        Sponge: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 16.        Liquid Embolics: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17.        Sclerosants: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18.        Precipitating Agents: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 19.        Others: Europe Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 20.        Europe Embolization Agents Market, by Application 2021 & 2028 (%)
Figure 21.        Oncology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22.        Neurology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23.        Urology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24.        Cardiology: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25.        Peripheral Vascular Diseases: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26.        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27.        Europe Embolization Agents Market Revenue Share, By End User (2021 and 2028)
Figure 28.        Hospitals: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29.        Cardiac Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30.        Ambulatory Surgical Centers: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 31.        Others: Europe Embolization Agents Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32.        Europe: Embolization Agents Market, by Key Country – Revenue (2021) (USD Million)
Figure 33.        Europe: Embolization Agents Market, by Country, 2021 & 2028 (%)
Figure 34.        Germany: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 35.        France: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 36.        UK: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 37.        Spain: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 38.        Italy: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 39.        Rest of Europe: Embolization Agents Market– Revenue and Forecast to 2028 (US$ Million)
Figure 40.        Impact of COVID-19 Pandemic in European Country Markets

Abbott
Boston Scientific Corporation
Cook Medical LLC
DePuy Synthes
KANEKA CORPORATION
Medtronic
Merit Medical Systems Inc
Penumbra, Inc.
Stryker Corporation
Terumo Corporation

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe Embolization Agents Market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe Embolization Agents Market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Embolization Agents Market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Report Code

Full Name

Country Name

Email Id

Phone Number

Job Title

Company

Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name Published Date

Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv.. May 2022

Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P.. May 2022

Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat.. May 2022

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount

Subscription Member Price: FREE
Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.